These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 25989360)

  • 21. Long-Term Persistence of Donor Alveolar Macrophages in Human Lung Transplant Recipients That Influences Donor-Specific Immune Responses.
    Nayak DK; Zhou F; Xu M; Huang J; Tsuji M; Hachem R; Mohanakumar T
    Am J Transplant; 2016 Aug; 16(8):2300-11. PubMed ID: 27062199
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The fraction of sensitization among lung transplant recipients in a transplant center in Japan.
    Kumata S; Hirama T; Watanabe Y; Oishi H; Niikawa H; Akiba M; Tikkanen J; Okada Y
    BMC Pulm Med; 2020 Oct; 20(1):256. PubMed ID: 33008353
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Lower frequency of the HLA-G UTR-4 haplotype in women with unexplained recurrent miscarriage.
    Meuleman T; Drabbels J; van Lith JMM; Dekkers OM; Rozemuller E; Cretu-Stancu M; Claas FHJ; Bloemenkamp KWM; Eikmans M
    J Reprod Immunol; 2018 Apr; 126():46-52. PubMed ID: 29481987
    [TBL] [Abstract][Full Text] [Related]  

  • 24. De novo donor HLA-specific antibodies predict development of bronchiolitis obliterans syndrome after lung transplantation.
    Safavi S; Robinson DR; Soresi S; Carby M; Smith JD
    J Heart Lung Transplant; 2014 Dec; 33(12):1273-81. PubMed ID: 25130554
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Haplotypes of the HLA-G 3' Untranslated Region Respond to Endogenous Factors of HLA-G+ and HLA-G- Cell Lines Differentially.
    Poras I; Yaghi L; Martelli-Palomino G; Mendes-Junior CT; Muniz YC; Cagnin NF; Sgorla de Almeida B; Castelli EC; Carosella ED; Donadi EA; Moreau P
    PLoS One; 2017; 12(1):e0169032. PubMed ID: 28045999
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The Autoimmune-Associated Single Nucleotide Polymorphism Within
    Budding K; van Setten J; van de Graaf EA; van Rossum OA; Kardol-Hoefnagel T; Kwakkel-van Erp JM; Oudijk ED; Hack CE; Otten HG
    Front Immunol; 2018; 9():3105. PubMed ID: 30705675
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Donor-specific antibody characteristics, including persistence and complement-binding capacity, increase risk for chronic lung allograft dysfunction.
    Iasella CJ; Ensor CR; Marrari M; Mangiola M; Xu Q; Nolley E; Moore CA; Morrell MR; Pilewski JM; Sanchez PG; McDyer JF; Zeevi A
    J Heart Lung Transplant; 2020 Dec; 39(12):1417-1425. PubMed ID: 32981841
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Incidence and impact of chronic lung allograft dysfunction after lung transplantation - single-center 14-year experience.
    Nykänen A; Raivio P; Peräkylä L; Stark C; Huuskonen A; Lemström K; Halme M; Hämmäinen P
    Scand Cardiovasc J; 2020 Jun; 54(3):192-199. PubMed ID: 32148103
    [No Abstract]   [Full Text] [Related]  

  • 29. Evaluation of current strategies for surveillance and management of donor-specific antibodies: Single-center study.
    Sullivan D; Ahn C; Gao A; Lacelle C; Torres F; Bollineni S; Banga A; Mullins J; Mohanka M; Ring S; Wait M; Peltz M; Duddupudi P; Surapaneni D; Kaza V
    Clin Transplant; 2018 Jul; 32(7):e13285. PubMed ID: 29774598
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Association of soluble HLA-G with acute rejection episodes and early development of bronchiolitis obliterans in lung transplantation.
    White SR; Floreth T; Liao C; Bhorade SM
    PLoS One; 2014; 9(7):e103643. PubMed ID: 25068264
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The plasma levels of soluble HLA-G molecules correlate directly with CD34+ cell concentration and HLA-G 14bp insertion/insertion polymorphism in cord blood donors.
    Capittini C; Bergamaschi P; Sachetto S; Truglio M; Viola M; Marchesi A; Genovese V; Romano B; Guarene M; Poma R; Martinetti M; Tinelli C; Salvaneschi L
    Blood Transfus; 2014 Jan; 12 Suppl 1(Suppl 1):s361-6. PubMed ID: 23399358
    [TBL] [Abstract][Full Text] [Related]  

  • 32. FCGR3A and FCGR2A Genotypes Differentially Impact Allograft Rejection and Patients' Survival After Lung Transplant.
    Paul P; Pedini P; Lyonnet L; Di Cristofaro J; Loundou A; Pelardy M; Basire A; Dignat-George F; Chiaroni J; Thomas P; Reynaud-Gaubert M; Picard C
    Front Immunol; 2019; 10():1208. PubMed ID: 31249568
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Spectrum of chronic lung allograft pathology in a mouse minor-mismatched orthotopic lung transplant model.
    Martinu T; Oishi H; Juvet SC; Cypel M; Liu M; Berry GJ; Hwang DM; Keshavjee S
    Am J Transplant; 2019 Jan; 19(1):247-258. PubMed ID: 30378739
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prophylactic Azithromycin Therapy After Lung Transplantation: Post hoc Analysis of a Randomized Controlled Trial.
    Ruttens D; Verleden SE; Vandermeulen E; Bellon H; Vanaudenaerde BM; Somers J; Schoonis A; Schaevers V; Van Raemdonck DE; Neyrinck A; Dupont LJ; Yserbyt J; Verleden GM; Vos R
    Am J Transplant; 2016 Jan; 16(1):254-61. PubMed ID: 26372728
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Donor-specific antibodies are associated with antibody-mediated rejection, acute cellular rejection, bronchiolitis obliterans syndrome, and cystic fibrosis after lung transplantation.
    Lobo LJ; Aris RM; Schmitz J; Neuringer IP
    J Heart Lung Transplant; 2013 Jan; 32(1):70-7. PubMed ID: 23260706
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Lung transplantation in patients with pretransplantation donor-specific antibodies detected by Luminex assay.
    Brugière O; Suberbielle C; Thabut G; Lhuillier E; Dauriat G; Metivier AC; Gautreau C; Charron D; Mal H; Parquin F; Stern M
    Transplantation; 2013 Mar; 95(5):761-5. PubMed ID: 23296148
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Validation of a post-transplant chronic lung allograft dysfunction classification system.
    Van Herck A; Verleden SE; Sacreas A; Heigl T; Vanaudenaerde BM; Dupont LJ; Yserbyt J; Verbeken EK; Neyrinck AP; Van Raemdonck D; Verleden GM; Vos R
    J Heart Lung Transplant; 2019 Feb; 38(2):166-173. PubMed ID: 30391199
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Soluble HLA-G Expression Inversely Correlates With Fetal Microchimerism Levels in Peripheral Blood From Women With Scleroderma.
    Di Cristofaro J; Karlmark KR; Kanaan SB; Azzouz DF; El Haddad M; Hubert L; Farge-Bancel D; Granel B; Harlé JR; Hachulla E; Pardoux E; Roudier J; Picard C; Lambert NC
    Front Immunol; 2018; 9():1685. PubMed ID: 30158921
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Bronchiolitis obliterans syndrome-free survival after lung transplantation: An International Society for Heart and Lung Transplantation Thoracic Transplant Registry analysis.
    Kulkarni HS; Cherikh WS; Chambers DC; Garcia VC; Hachem RR; Kreisel D; Puri V; Kozower BD; Byers DE; Witt CA; Alexander-Brett J; Aguilar PR; Tague LK; Furuya Y; Patterson GA; Trulock EP; Yusen RD
    J Heart Lung Transplant; 2019 Jan; 38(1):5-16. PubMed ID: 30391193
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Quantitative chest CT for subtyping chronic lung allograft dysfunction and its association with survival.
    Horie M; Salazar P; Saito T; Binnie M; Brock K; Yasufuku K; Azad S; Keshavjee S; Martinu T; Paul N
    Clin Transplant; 2018 May; 32(5):e13233. PubMed ID: 29637624
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.